Cathie Wood is being remarkably bold this time! With CPI fueling rate-hike pressure, she is increasing positions against the trend. What is she betting on?
Reducing positions
1. Palantir $PLTR
Following a recent surge in its share price, its valuation appears expensive. The fund is taking partial profits, reducing concentration in a single holding, and shifting capital toward AI names with stronger infrastructure characteristics.
2. Shopify $SHOP
Its e-commerce platform business remains solid, but growth has slowed from its earlier pace and remains sensitive to macroeconomic consumption trends. The fund is continuing to trim the position slightly to make room for AI and biotech stocks with greater growth potential.
3. Toast $TOST
The restaurant software provider has decent fundamentals, but its share price has been highly volatile recently and its growth story is relatively mature. The fund is significantly reducing the position to lock in some gains and optimize the portfolio.
4. Personalis $PSNL
The genomics testing company is making progress on its clinical programs, but commercialization pace and competitive pressure remain concerns. The fund is trimming the position consecutively to control risk exposure.
5. 10x Genomics $TXG
It leads in single-cell sequencing technology, but valuations for life science tool companies are contracting. The fund is reducing the position to lower its weighting in this segment.
6. Twist Bioscience $TWST
A leader in synthetic biology with high technological barriers, but facing short-term pressure from orders and capital expenditures, it is being trimmed slightly.
7. DraftKings $DKNG
The sports betting platform has active users, but regulatory and competitive pressures are intensifying. The fund is continuing to reduce the position and shifting toward more certain technology and defense opportunities.
8. CareDx $CDNA
Its transplant diagnostics business is stable, but its growth potential is relatively limited. ARK is continuing to trim the position slightly, allocating capital to more cutting-edge gene-editing and AI opportunities.
Increasing positions
9. CoreWeave $CRWV
An AI cloud computing provider with large-scale NVIDIA GPU clusters and long-term customer contracts, it is in a central position amid the data center construction boom. The fund is aggressively adding to the position against the trend as the stock plunges 15%, bullish on its long-term strategic positioning as AI infrastructure.
10. Cerebras $CBRS
It develops its own wafer-scale AI chips with outstanding computing density and energy efficiency, and has deep partnerships with major customers such as OpenAI. The fund is adding to the position consecutively, betting on its differentiated advantages in large-scale training.
11. Meta $META
Its advertising business generates strong cash flow, and it is investing heavily in AI agents and models such as Muse. This could further AI-enable social media and advertising. The fund is adding to the position over multiple days, bullish on its potential to bring AI to consumers.
12. Freenome $FRNM
Its blood-based early cancer detection technology is at a critical stage of clinical validation. If approved, it could unlock a massive market. The fund is increasing the position slightly to gain exposure to a high-confidence biotech breakthrough.
13. Kodiak AI $KDK
Its autonomous trucking technology is progressing and targets lower costs and greater efficiency in logistics. It operates at the intersection of physical AI and autonomous transportation. The fund is increasing the position to capture opportunities arising from the next generation of transportation.
Others fear rate hikes, while Cathie Wood is busy buying the dip!
Reducing positions
1. Palantir $PLTR
Following a recent surge in its share price, its valuation appears expensive. The fund is taking partial profits, reducing concentration in a single holding, and shifting capital toward AI names with stronger infrastructure characteristics.
2. Shopify $SHOP
Its e-commerce platform business remains solid, but growth has slowed from its earlier pace and remains sensitive to macroeconomic consumption trends. The fund is continuing to trim the position slightly to make room for AI and biotech stocks with greater growth potential.
3. Toast $TOST
The restaurant software provider has decent fundamentals, but its share price has been highly volatile recently and its growth story is relatively mature. The fund is significantly reducing the position to lock in some gains and optimize the portfolio.
4. Personalis $PSNL
The genomics testing company is making progress on its clinical programs, but commercialization pace and competitive pressure remain concerns. The fund is trimming the position consecutively to control risk exposure.
5. 10x Genomics $TXG
It leads in single-cell sequencing technology, but valuations for life science tool companies are contracting. The fund is reducing the position to lower its weighting in this segment.
6. Twist Bioscience $TWST
A leader in synthetic biology with high technological barriers, but facing short-term pressure from orders and capital expenditures, it is being trimmed slightly.
7. DraftKings $DKNG
The sports betting platform has active users, but regulatory and competitive pressures are intensifying. The fund is continuing to reduce the position and shifting toward more certain technology and defense opportunities.
8. CareDx $CDNA
Its transplant diagnostics business is stable, but its growth potential is relatively limited. ARK is continuing to trim the position slightly, allocating capital to more cutting-edge gene-editing and AI opportunities.
Increasing positions
9. CoreWeave $CRWV
An AI cloud computing provider with large-scale NVIDIA GPU clusters and long-term customer contracts, it is in a central position amid the data center construction boom. The fund is aggressively adding to the position against the trend as the stock plunges 15%, bullish on its long-term strategic positioning as AI infrastructure.
10. Cerebras $CBRS
It develops its own wafer-scale AI chips with outstanding computing density and energy efficiency, and has deep partnerships with major customers such as OpenAI. The fund is adding to the position consecutively, betting on its differentiated advantages in large-scale training.
11. Meta $META
Its advertising business generates strong cash flow, and it is investing heavily in AI agents and models such as Muse. This could further AI-enable social media and advertising. The fund is adding to the position over multiple days, bullish on its potential to bring AI to consumers.
12. Freenome $FRNM
Its blood-based early cancer detection technology is at a critical stage of clinical validation. If approved, it could unlock a massive market. The fund is increasing the position slightly to gain exposure to a high-confidence biotech breakthrough.
13. Kodiak AI $KDK
Its autonomous trucking technology is progressing and targets lower costs and greater efficiency in logistics. It operates at the intersection of physical AI and autonomous transportation. The fund is increasing the position to capture opportunities arising from the next generation of transportation.
Others fear rate hikes, while Cathie Wood is busy buying the dip!
1